Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane, specifically its phospholipids and anionic surface components, is a critical therapeutic target due to its essential role in maintaining cellular homeostasis and its distinct composition compared to eukaryotic membranes (Source 1.2.1, 1.5.3). In Gram-positive bacteria, the membrane is characterized by high levels of anionic phospholipids such as phosphatidylglycerol (PG) and cardiolipin (CL), along with lipoteichoic acids (Source 1.1.1, 1.2.2). Gram-negative bacteria feature an outer membrane dominated by lipopolysaccharides (LPS) and an inner membrane with a high proportion of anionic lipids (Source 1.3.3, 1.3.5). These negatively charged components facilitate the selective binding of cationic antimicrobial agents, such as polymyxins and daptomycin, through electrostatic interactions (Source 1.3.2, 1.4.1). Upon binding, these drugs disrupt the membrane's structural integrity, causing depolarization, pore formation, and the rapid leakage of essential intracellular ions and molecules, ultimately leading to cell death (Source 1.3.1, 1.4.5). While highly effective against multidrug-resistant pathogens, targeting the bacterial membrane presents challenges, including potential toxicity to host cells and the development of resistance through modifications in lipid composition or surface charge (Source 1.2.4, 1.3.1).
Disruption of membrane integrity through electrostatic binding to anionic phospholipids and surface components, leading to depolarization, pore formation, and leakage of intracellular contents (Source 1.3.1, 1.4.5).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane phospholipids and anionic surface components.